https://www.selleckchem.com/pr....oducts/as1842856.htm
The primary endpoint is the change of index of microcirculatory resistance (ΔIMR) at 12-month follow-up. The present study will be the first randomized control study to evaluate the efficacy and safety of STDP on SCAD patients, CAD with normal FFR and CMVD, which will provide a broader idea and more experimental basis for improving the treatment of CMVD. This is a protocol for the randomized clinical trial which has been registered in the Chinese clinical Trial Registry with an identifier ChiCTR2000032429. This is a protocol for the r
Like
Comment
Share
